Samenwerkingspartners vinden in Europa?

A novel proprietary assay suitable for both cGMP (cyclic guanosine monophosphate) or cAMP (cyclic adenosine monophosphate) specific PDE activity measurement for in vitro determination of any PDE enzyme activity has been developed by a Hungarian university. The assay can be used to reliably measure PDE inhibitors in a wide range including simple water soluble components and also lipophilic compounds or natural extracts. Partners for licence agreement, and commercial cooperation are awaited.

A Hungarian University has developed and validated a method for coating of bio-absorbable sutures with various proteins, which help the attachment of bone marrow derived stem cells during and incubations period. Results show increased absorption of sutures and improved wound healing compared to regular sutures. The University is looking for an out-licensing or co-development partner.

A Hungarian technology transfer agency is offering a novel automatic toileting aid technology for bedridden persons such as elderly, patients, and disabled. With its automatized system the offered technology significantly improves the personal hygiene and comfort. The company is looking for business partners for Commercial Agreement with technical consultancy, Licensing Agreement and Financial resources.

The Hungarian SME offers an integrated technological system of bioengineering, biotechnology and climate protection processes in different sizes and with diverse technical content. The system is adaptable to various local conditions. Main advantages are the worldwide applicability, negative or zero carbon emission, high climate, environmental and health protection effect and economic efficiency. The company looks for partners for licensing, financial and technical-commercial cooperation.

A Hungarian company has developed a new additive, synergic blends of botanicals, validated in studies on Alzheimer's disease. The technology can be blended into various food and use as a health-preserving functional food. The company is looking for technical partners for further development and/or adaptation, financial partners, licence or joint venture partners.

The Hungarian university developed a new natural mouthwash high in flavonoids and suitable for long term dental prevention. Tested on the majority of oral bacteria and fungi species, it diminishes them by 95%, however, it does not eliminate them totally. It reduces the healing time of the oral wounds, has no effect on the protein compounds of the saliva, has proper pH and does not discolour the teeth. Partners are sought for out-licensing, technological collaboration or financial support.

A Hungarian biotech SME has developed a bioinformatic data analysis system for the interpretation of biological data, assisting the researcher in revealing the genetic background of diseases or providing an answer to related research questions. The company is seeking partners from Pharma, CROs (Contract Research Organizations) and clinical research institutes with products and/or technologies in need of further development. Partners for licence agreement/technical cooperation are awaited.

A Hungarian biotech SME has developed a biobanking system which handles samples and the related experimental, clinical, environmental and lifestyle data. It offers unparalleled convenience for the researcher – as well as external customers – in finding samples and data required by a particular project and then manage that data to provide an optimal base for answering research questions. Cooperation partners for licence agreement or technical cooperation are awaited.

A Hungarian medical research institute has developed, based on naturally occurring substance (kynurenic acid) research, a molecule with highly protective effects in the gastrointestinal system. The company seeks industrial partners interested in establishing a license or joint venture agreement.

A Hungarian University has developed an easy to use new method and software to recognize amblyopia in early childhood stage. The technology is more sensitive and requires shorter time of examination than other existing technologies. The University is seeking for collaboration in the framework of license, co-development, manufacturing, techno-commercial agreement with industrial and/or research partners from the medical equipment and diagnostics sectors.